Ravi Rauniyar

Ravi Rauniyar serves as the Senior Director and Head of US Marketing at Orchard Therapeutics, overseeing US marketing and launch preparedness for gene therapy products targeting rare neurometabolic and primary immune disorders since August 2019. Previously, Ravi held the position of Global Marketing Director, where the focus was on the global commercial strategy for gene therapy products from preclinical stages to phase III. Prior experience includes roles in pre-commercial brand development at Alnylam Pharmaceuticals, where responsibilities included market development for Givosiran and Fitusiran, as well as serving as Global Brand Lead for Hemophilia Marketing at Shire. Ravi's career began at AbbVie, encompassing various marketing management roles in hematology, immunology, and market research, alongside time as a Research Associate at Harvard Medical School. Educational qualifications include an MBA from Harvard Business School, a Bachelor's Degree in Molecular Biology and Math from Bennington College, and a certificate in Digital Media and Marketing from Duke University.